Abpro Bio Co (195990) Fair Value & Analysis
Industrials · KR · Market cap 26.4B KRW
Fair value as of: Jul 7, 2026
From 3 valuation models · updated today
Fair value updated Jul 7, 2026 — revised from 8,540 KRW to 1,142 KRW (−86.6%) since Jun 24, 2026. Share price −26.3% over the past month.
Price vs Fair Value (12 months)
12‑month range 680.00 KRW – 3,950 KRW · fair‑value band 1,043 KRW – 1,292 KRW · the 700.00 KRW price screens below the 1,142 KRW fair value. As of Jul 7, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Abpro Bio Co (195990) currently trades at 700.00 KRW, while our model-based Fair Value estimate is 1,142 KRW — implying the stock looks roughly 63.1% undervalued today. We read business quality at 36/100 (below-average quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
Trailing-twelve-month revenue stands at 30.9B KRW. Revenue declined 11.1% year over year. It earns a return on equity of -53.9%. Net debt stands at 10.7B KRW. Fundamentals as of Jul 7, 2026
Our scenario range runs from 1,043 KRW (bear case) to 1,292 KRW (bull case); at 700.00 KRW, the current price sits below that range. For context, the median of 10 Industrials peers we cover trades at -43% fair-value upside — at 63%, 195990 screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 7, 2026. TTM = trailing twelve months.
About the company
Abpro Bio Co., Ltd. manufactures and sells machine tools in South Korea and internationally. It offers tapping centers, spindle machines, machining and turning centers, and machining centers with long table. The company was founded in 1991 and is headquartered in Daegu, South Korea.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Abpro Bio Co reported revenue of 31.9B KRW in FY2025 versus 32.9B KRW in FY2021, a compound −0.8%/yr. Reported net income was −48.9B KRW in FY2025.
Is 195990 fairly valued? → Check now
Similar stocks
10 more Specialty Industrial Machinery stocks, each showing price versus our Fair Value estimate (as of Jul 7, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| GE Vernova Inc 1GEV | €967.60 | €212.97 | -78% |
| 1SIE 1SIE | €284.30 | €122.46 | -57% |
| SIEGY SIEGY | $155.06 | $89.54 | -42% |
| SMAWF SMAWF | $307.12 | $176.28 | -43% |
| SMNS SMNS | C$31.76 | C$23.45 | -26% |
| SIE SIE | €269.80 | €161.17 | -40% |
| Schneider Electric S.E. SBGSF | $334.00 | $148.44 | -56% |
| Siemens Energy AG SMEGF | $182.39 | $47.02 | -74% |
| Eaton Corporation ETN | $375.46 | $194.62 | -48% |
| Atlas Copco AB ATCOA | kr 179.35 | kr 122.65 | -32% |
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is Abpro Bio Co (195990) undervalued?
What is the fair value of 195990?
What is the quality score of 195990?
What is the revenue of Abpro Bio Co (195990)?
What is the net profit margin of 195990?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.